𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer

✍ Scribed by Michio Maemura; Yuichi Iino; Takao Yokoe; Jun Horiguchi; Hiroyuki Takei; Yukio Koibuchi; Yoshio Horii; Izumi Takeyoshi; Susumu Ohwada; Yasuo Morishita

Book ID
117469003
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
68 KB
Volume
126
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum epidermal growth factor receptor/H
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer
✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a